"Fluticasone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.
| Descriptor ID |
D000068298
|
| MeSH Number(s) |
D04.210.500.054.079.129.114
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fluticasone".
Below are MeSH descriptors whose meaning is more specific than "Fluticasone".
This graph shows the total number of publications written about "Fluticasone" by people in this website by year, and whether "Fluticasone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 4 | 7 | 11 |
| 2018 | 1 | 3 | 4 |
| 2019 | 1 | 0 | 1 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Fluticasone" by people in Profiles.
-
Two cases of chronic obstructive pulmonary disease evaluated by dynamic-ventilatory digital radiography for pulmonary function and assessment of treatment efficacy. Respir Investig. 2021 Nov; 59(6):871-875.
-
Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients". Am J Otolaryngol. 2021 Sep-Oct; 42(5):103103.
-
Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells. Front Cell Infect Microbiol. 2021; 11:655666.
-
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients. Am J Otolaryngol. 2021 Jul-Aug; 42(4):103009.
-
The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated. Am J Otolaryngol. 2021 Jul-Aug; 42(4):103008.
-
SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients. J Appl Lab Med. 2021 03 01; 6(2):486-490.
-
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients. Am J Otolaryngol. 2021 May-Jun; 42(3):102892.
-
Comparison of efficacy of fluticasone propionate versus clarithromycin for postoperative treatment of different phenotypic chronic rhinosinusitis: a randomized controlled trial. Rhinology. 2019 Apr 01; 57(2):101-109.
-
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respir Res. 2018 Dec 13; 19(1):251.
-
Double combination inhalers in COPD: How to get your head around this data. Respirology. 2018 12; 23(12):1088-1089.